Core Viewpoint - The company, Stone Four Pharmaceutical Group, has received production registration approvals from the National Medical Products Administration for seven pharmaceutical products, indicating a significant advancement in its product portfolio and market positioning [1]. Group 1: Product Approvals - The company has obtained approval for Arginine Perindopril Tablets (10mg), classified as a Class 4 chemical drug, making it the second domestic company to receive this approval. This product is primarily used for treating hypertension and congestive heart failure [1]. - The company has also received approval for Progesterone Injection (II) (1.112ml: 25mg), classified as a Class 3 chemical drug, which is used for progesterone supplementation in assisted reproductive technology (ART) [1]. - Approval has been granted for Labetalol Hydrochloride Injection (20ml: 100mg), also a Class 3 chemical drug, used for various types of hypertension, especially hypertensive crises, and for blood pressure control before surgery [1]. - Calcium Chloride Injection (10ml: 1g), classified as a Class 3 chemical drug, is approved for treating acute hypocalcemia and magnesium poisoning [1]. - The company has received approval for Compound Electrolyte Acetate Sodium Injection (500ml), a Class 3 chemical drug, used for treating isotonic dehydration with mild acidosis [1]. - Approval has been granted for Compound Electrolyte Injection (V) (500ml), classified as a Class 3 chemical drug, which serves as a source of water and electrolytes for adults [1]. - The company has also received approval for Levosalbutamol Hydrochloride Nebulization Solution (3ml: 0.63mg), a Class 3 chemical drug, used for treating or preventing bronchospasm in adults and children over six years old with reversible airway obstructive diseases [1].